This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Sam Bunting launches Flawless...
Business product launch

Sam Bunting launches Flawless Neutralising Gel Roller

Analysis based on 6 articles · First reported Dec 29, 2025 · Last updated Jan 11, 2026

Sentiment
60
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The launch of Sam Bunting's new Flawless Neutralising Gel Roller could impact the competitive landscape of the skincare market, potentially affecting sales of alternative products from entities like Medik8, L Oréal — La Roche-Posay, and Dr. Barbara Sturm. The positive customer feedback and clinical trial results suggest a strong market entry for Sam Bunting's product.

cosmetics skincare
Event Summary

Sam Bunting, a cosmetic dermatologist, has launched the Flawless Neutralising Gel Roller, an advanced version of her popular Flawless Neutralising Gel. This new product features a precision-engineered roller applicator for targeted prevention of breakouts on the face and body, addressing the common mistake of treating spots individually rather than by zone. The formula contains 5% Azelaic Acid, 2% Salicylic Acid, 0.5% Bakuchiol, and 5% Squalane, aiming to reduce redness, clear pores, minimize dark marks, and hydrate the skin without causing dryness or irritation. An eight-week clinical trial showed a significant reduction in blemishes. The product, retailing at £42, has received positive customer reviews, with many praising its effectiveness and the convenience of the roller applicator. It competes with other skincare products like Medik8's Blemish SOS, L Oréal — La Roche-Posay Effaclar A.I. Breakout Corrector, and Dr. Barbara Sturm's Ultimate Stinky Pimple Treatment.

Entities Involved
per
Sam Bunting
Sam Bunting, a cosmetic dermatologist, developed and launched the Flawless Neutralising Gel Roller, an advanced product designed to prevent breakouts.
Importance 100.0 Sentiment 70.0
priv
Medik8
Medik8 is mentioned as an alternative treatment option with its Blemish SOS product, offering competition in the skincare market.
Importance 20.0 Sentiment 0.0
priv
Dr. Barbara Sturm
Dr. Barbara Sturm offers an alternative salicylic-free treatment, catering to a specific segment of the skincare market.
Importance 20.0 Sentiment 0.0
subs
L Oréal — La Roche-Posay
L Oréal — La Roche-Posay is cited as an alternative, more affordable breakout corrector, indicating market competition.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.